Skip to main content
. 2024 Oct 25;22:130. doi: 10.1186/s12958-024-01298-4

Table 2.

Oocyte aspiration cycle characteristics of the patients among the DOR group, high-risk DOR group and NOR group

DOR High-risk DOR NOR p1 p2 p3
Oocytes aspiration
 No. of oocyte aspiration cycles, n 1153 682 2649
 No. of retrieved oocytes, n, mean ± SD 5.33±3.790 8.28±3.890 14.38±5.765 <0.001 <0.001 <0.001
 No. of MII oocytes, n, mean ± SD 4.85±3.297 7.23±3.559 12.47±5.359 <0.001 <0.001 <0.001
 Mature oocyte rates, % 88.5 87.4 86.5 0.146 <0.001 0.189
 No. of cycles with no oocyte retrieved, n (%) 39 (3.38) 3 (0.44) 5 (0.19) <0.001 <0.001 0.213
 No. of cycles with no MII oocyte retrieved, n (%) 26 (2.33) 3 (0.44) 3 (0.11) 0.003 <0.001 0.104
Insemination
 Methods of Insemination 1088 676 2641
 IVF, n (%) 748 (68.8) 435 (64.4) 1658 (62.8) 0.061 <0.001 0.475
 ICSI, n (%) 281 (25.8) 165 (24.4) 549 (20.8) 0.536 <0.001 0.046
 Half ICSI, n (%) 59 (5.4) 76 (11.2) 434 (16.4) <0.001 <0.001 0.001
Normal fertilization rates in MII oocyte cycles, %, mean ± SD
 IVF (%) 70.8±27.2 69.8±22.0 70.8±21.1 0.448 0.969 0.414
 ICSI (%) 75.3±29.8 79.6±21.1 76.1±18.5 0.052 0.617 0.083
 Half ICSI (%) 69.5±22.6 75.1±19.3 72.6±16.6 0.070 0.210 0.258
Embryos culture
 No. of cycles with viable embryos retrieved, n (%) 973(84.39) 654(95.89) 2618(98.83) <0.001 <0.001 <0.001
 No. of top-quality D3 embryos, n, mean ± SD 1.96±1.731 2.66±2.036 4.43±3.009 <0.001 <0.001 <0.001
 Top-quality D3 embryo rates, %, mean ± SD 52.1±36.0 50.6±30.7 49.6±25.9 0.318 0.023 0.432
 No. of blastocyst culture cycles, n (%) 572 (49.6) 491 (72.0) 2426 (91.6) <0.001 <0.001 <0.001
 No. of viable blastocysts in blastocyst culture cycles, n, mean ± SD 1.27±1.562 1.65±1.870 2.98±2.773 0.015 <0.001 <0.001
 Blastocyst rates per blastocyst culture cycles, %, mean ± SD 38.4±38.4 37.0±34.4 40.0±28.9 0.665 0.271 0.117
 No. of viable D3 embryos, n, mean ± SD 1.84±1.328 2.37±1.245 2.62±1.378 <0.001 <0.001 <0.001
 No. of viable blastocysts in oocyte aspiration cycles, n, mean ± SD 0.64±1.277 1.20±1.757 2.74±2.775 <0.001 <0.001 <0.001

p1 DOR group vs. high-risk DOR group, p2 DOR group vs. NOR group, p3 High-risk DOR group vs. NOR group, IVF In-vitro fertilization, ICSI Intracytoplasmic sperm injection, Half ICSI Half number of MII oocytes fertilized by in-vitro fertilization and half number of MII oocytes fertilized by intracytoplasmic sperm injection